EXAS EXACT Sciences Corporation

$56.43

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/2/2025

About EXACT Sciences Corporation

Exact Sciences Corporation offers cancer screening and diagnostic test products in the United States and internationally. The company is headquartered in Madison, Wisconsin.

Website: https://www.exactsciences.com

Sector
TRADE & SERVICES
Industry
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1124140
Address
441 CHARMANY DRIVE, MADISON, WI, US
Valuation
Market Cap
$7.72B
P/E Ratio
nan
PEG Ratio
-1.07
Price to Book
3.21
Performance
EPS
$-5.59
Dividend Yield
—
Profit Margin
-37.30%
ROE
-37.10%
Technicals
50D MA
$46.56
200D MA
$55.78
52W High
$72.83
52W Low
$39.97
Fundamentals
Shares Outstanding
186M
Target Price
$66.89
Beta
1.14

EXAS EPS Estimates vs Actual

● Estimated
● Actual

EXAS News & Sentiment

Oct 01, 2025 • Zacks Commentary BULLISH
Exact Sciences ( EXAS ) Just Flashed Golden Cross Signal: Do You Buy?
Is it a good or bad thing when a stock surpasses resistance at the 20-day simple moving average?
Sep 30, 2025 • Zacks Commentary NEUTRAL
DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute
Quest Diagnostics' Haystack Oncology joins Rutgers Cancer Institute to study how its ctDNA MRD test can guide therapy for stage II/III lung cancer.
Sep 26, 2025 • Motley Fool NEUTRAL
This Cancer Detection Pioneer Is Worth a Look
Multicancer detection tests are closing in on FDA approval and potentially major sales.
Sep 22, 2025 • Zacks Commentary BULLISH
Why Exact Sciences ( EXAS ) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Sep 18, 2025 • Benzinga SOMEWHAT-BULLISH
Peering Into Exact Sciences's Recent Short Interest - Exact Sciences ( NASDAQ:EXAS )
Exact Sciences's EXAS short interest as a percent of float has fallen 22.42% since its last report. According to exchange reported data, there are now 7.34 million shares sold short, which is 4.43% of all regular shares that are available for trading.
Sep 15, 2025 • Zacks Commentary BULLISH
Why Exact Sciences ( EXAS ) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Sentiment Snapshot

Average Sentiment Score:

0.186
50 articles with scored sentiment

Overall Sentiment:

Bullish

EXAS Reported Earnings

Feb 19, 2025
Dec 31, 2024 (Pre market)
0.09 Surprise
  • Reported EPS: $-0.24
  • Estimate: $-0.33
  • Whisper: —
  • Surprise %: 27.7%
Nov 05, 2024
Sep 30, 2024 (Post market)
0.0 Surprise
  • Reported EPS: $-0.21
  • Estimate: $-0.21
  • Whisper: —
  • Surprise %: 0.0%
Jul 31, 2024
Jun 30, 2024 (Post market)
0.23 Surprise
  • Reported EPS: $-0.09
  • Estimate: $-0.32
  • Whisper: —
  • Surprise %: 71.9%
May 08, 2024
Mar 31, 2024 (Post market)
-0.13 Surprise
  • Reported EPS: $-0.60
  • Estimate: $-0.47
  • Whisper: —
  • Surprise %: -27.7%
Feb 21, 2024
Dec 31, 2023 (Post market)
0.19 Surprise
  • Reported EPS: $-0.27
  • Estimate: $-0.46
  • Whisper: —
  • Surprise %: 41.3%
Nov 01, 2023
Sep 30, 2023 (Post market)
0.48 Surprise
  • Reported EPS: $0.00
  • Estimate: $-0.48
  • Whisper: —
  • Surprise %: 100.9%
Aug 01, 2023
Jun 30, 2023 (Post market)
0.06 Surprise
  • Reported EPS: $-0.45
  • Estimate: $-0.51
  • Whisper: —
  • Surprise %: 11.8%
May 09, 2023
Mar 31, 2023 (Post market)
0.33 Surprise
  • Reported EPS: $-0.42
  • Estimate: $-0.75
  • Whisper: —
  • Surprise %: 44.0%
Feb 21, 2023
Dec 31, 2022 (Post market)
0.12 Surprise
  • Reported EPS: $-0.72
  • Estimate: $-0.84
  • Whisper: —
  • Surprise %: 14.3%

Financials